ASPA Polyclonal Antibody

Background:
This gene encodes an enzyme that catalyzes the conversion of N-acetyl_L-aspartic acid (NAA) to aspartate and acetate. NAA is abundant in the brain where hydrolysis by aspartoacylase is thought to help maintain white matter. This protein is an NAA scavenger in other tissues. Mutations in this gene cause Canavan disease. Alternatively spliced transcript variants have been found for this gene.

Research Area: Cancer, Metabolism, Neuroscience, Signal Transduction

Synonyms:
ACY 2, ACY-2, ACY2, ACY2, Aminoacylase 2, Aminoacylase-2, Aminoacylase2, ASP, ASPA, Aspartoacylase (aminoacylase 2, Canavan disease), Aspartoacylase (Canavan disease), Aspartoacylase, NUR 7, NUR7, OTTMUSP00000006437, RP23-213I10.1, Small lethargic

Immunogen: Recombinant protein of human ASPA

Swissprot: P45381
Gene Accession: BC029128

Calculated MW: 36 kDa

Purification Method: Affinity purification

Buffer: PBS with 0.05% sodium azide and 50% glycerol, PH7.4

Concentration: 0.4 mg/mL
Dilution: WB 1:1000-1:5000, IHC 1:100-1:300

Storage:
Store at -20°C. Avoid freeze / thaw cycles.

Alternative for product with catalog number:
sc-109208/sc-109209/sc-109212/sc-98734